Follow
Dr. C N Hemalatha
Dr. C N Hemalatha
Verified email at psgpharma.ac.in
Title
Cited by
Cited by
Year
Application of 3d qsar and docking studies in optimization of perylene diimides as anti cancer agent
CN Hemalatha, VA Muthkumar
Indian J. Pharm. Educ. Res 52 (4), 666-675, 2018
132018
A Comprehensive Review on the Role of Tau Proteins in Alzheimer's Pathology
MV Aanandhi, A Niventhi, T Rujaswini, CN Hemalatha, D Praveen
Research Journal of Pharmacy and Technology 11 (2), 788-790, 2018
112018
Virtual screening studies to design dual inhibitors of integrase and caspase; QSAR, Pharmacophore modeling and docking studies.
SG Vijey Aanandhi Muthukumar, Hemalatha Catna Nagaraj, Debojit Bhattacherjee
International Journal of Pharmacy and Pharmaceutical Sciences 5 (3), 95-102., 2013
8*2013
Insilico approach of interaction studies in Bacopa monnieri compounds targeting multi-proteins for Alzheimer's Disease
SL Kanthamma, J Kriszhnamurthi, CN Hemalathaa, MV Aanandhi
Research Journal of Pharmacy and Technology 11 (4), 1522-1526, 2018
52018
G-QUADRUPLEX LIGANDS AS STABILIZER TARGETING TELOMERASE ENZYME AS ANTI CANCER AGENTS
MVA C N Hemalatha
Asian Journal of Pharmaceutical and Clinical Research 10 (8), 50-53, 2017
52017
Evaluation of anti-cancer and anti-oxidant activity of Cissus quandrangularis extracts in DMBA induced mammary carcinomas
CN Hemalatha, K Anbarasu, VM Aanandhi
Research Journal of Pharmacy and Technology 10 (1), 293-300, 2017
52017
G-Quadruplex Ligands as Stabilizer targeting Telomerase as Anti-Cancer Agents
MVA C N Hemalatha
Mother Therasa Post Graduate and Research Institute of Helalth Sciences …, 2016
5*2016
Evalution and Molecular Docking of Benzimidazole and its Derivatives as a Potent Antibacterial Agent
K Chandrasekar, B Kumar, A Saravanan, A Victor, S Sivaraj, M Haridoss
Biomedical and Pharmacology Journal 12 (04), 1835-1847, 2019
42019
RP-HPLC method development and validation for the estimation of Midostaurin in bulk and pharmaceutical dosage form
H Narayanaswamy, S Gejalakshmi, CN Hemalatha, V Pavankumar
International Journal of Research in Pharmaceutical Sciences 11 (2020), 5108 …, 2020
32020
3D QSAR AND DOCKING STUDY OF PERYLENE-DI IMIDES ANALOGUES AS POTENT APOPTOSIS INDUCER AND EFFICACIOUS ANTICANCER AGENT.
CN Hemalatha, AM Vijey
Indian Drugs 54 (12), 2017
32017
Synthesis characterization and biological evaluation of Isoxazole and pyrazole derivatives from β- di ketones.
SP Vijey Aanandhi Muthukumar, Sujatha Ramasamy, Sharmila Alladi, Hemalatha ...
Journal of Pharmacy Research 4 (November 12, 2011,), 2011
32011
Synthesis of some novel perylene di imides and evaluation of their anti cancer activity
C Hemalatha, M Vijey Aanandhi
Asian J Pharm Clin Res 11, 1-9, 2018
22018
Virtual screening studies of two closely related withanolides to control cell proliferation and induction of cell senescence
S Rashmi, S Nivethitha, CN Hemalatha, MV Aanandhi
Rasayan J Chem 11 (1), 339-44, 2018
12018
Formulation & Characterization of Nanoparticles Loaded Cefadroxil.
VM Hemalatha C N, YeswanthPrasannaKumar
Research Journal of Pharmacy and Technology 10 (Issue 1), 2016
1*2016
Comparative of Antioxidant property of Actinidia Deliciosa extracts by DPPH Assay
CN Hemalatha
Research Journal of Pharmacy and Technology 17 (3), 1246-1249, 2024
2024
In-silico ANALYSIS AND MOLECULAR DOCKING STUDIES OF NOVEL THIAZOLIDINEDIONE DERIVATIVES AGAINST PPAR-γ
B Geetha, N Harikrishnan, P Sharmili, EE Rani, A Haripriya, ...
Rasayan Journal of Chemistry 15 (2), 2022
2022
Targeting Telomeric G-Quadruplex Complex by Perylene Diimides for Anticancer Activity: An In-Silico Study.
H CN
Current Trends in Biotechnology & Pharmacy, 2020
2020
Methods of induction of Alzheimer's disease in rat and mice.
CN Hemalatha, S Dhanalakshmi, S Indumathi, D Pavithra, N Harikrishnan
Drug Invention Today 14 (3), 2020
2020
Reimposing of marketed drugs in treatment of COVID 19 by insilicomethods
CN Hemalatha, B Hemamalini, N Harikrishnan
International Journal of Pharmaceutical Research, 2714-2719, 2020
2020
Role of Histone Deacetylase (HDAC) Inhibitors for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
CN Hemalatha, N Janani, S Vanishree, N Harikrishnan
Research Journal of Pharmacy and Technology 13 (6), 2963-2965, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20